Pre-exposure Prophylaxis
89 results
1 - 89Pre-exposure Prophylaxis
HIV
- Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
- Dear Colleague: Preliminary Data on Pre-Exposure Prophylaxis Coverage Released
- Notice of Funding Opportunity PS23-001: Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP)
- February 7 is National Black HIV/AIDS Awareness Day (NBHAAD)
Anthrax, Pre-exposure and Post-Exposure Prevention
Anthrax vaccine
Anthrax vaccine
Post-exposure prophylaxis
Emtricitabine
Emtricitabine
Yersinia pestis
Pemgarda (pemivibart)
Rabies vaccines
Treponema pallidum (syphilis)
Coronavirus COVID-19 (SARS-CoV-2)
Rabies
Coronavirus COVID-19 (SARS-CoV-2)
Molnupiravir
Molnupiravir
Preventing HIV in 2025: Primary Care and Psychiatry at the Forefront of Prep
Intravenous immune globulin
Intravenous immune globulin
Hepatitis C
Zanamivir
Hepatitis A
Monkeypox Update: Common Questions Answered by Dr. Paul Auwaerter of Johns Hopkins
mpox
mpox
Chlamydia trachomatis
Screening for and Prevention of Infectious Diseases in Special Populations
Smallpox
COVID-19 Update with Dr. Paul Auwaerter of Johns Hopkins : Omicron Variant, Testing, and Treatment
Toxoplasma gondii
Pregnancy and perinatal transmission
Japanese Encephalitis Vaccine
Japanese Encephalitis Vaccine
Beta-lactam allergy
Primary HIV Infection
Leptospira spp.
Diarrhea
Cytomegalovirus
Chloroquine
Ertapenem
Prostatitis, Acute Bacterial
Plasmodium
Pneumocystis jirovecii pneumonia
Antimicrobials with Special Precautions in Diabetes
Varicella-zoster virus
Voriconazole
Voriconazole
Clostridioides (ex. Clostridium) difficile